The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 406.00
Bid: 401.00
Ask: 412.50
Change: -8.00 (-1.93%)
Spread: 11.50 (2.868%)
Open: 407.00
High: 409.50
Low: 406.00
Prev. Close: 414.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covered Bonds: interest rate replacement

3 May 2023 11:38

RNS Number : 2871Y
Banco Santander S.A.
03 May 2023
 

 

Banco Santander, S.A. (the "Issuer" or the "Bank"), in compliance with the Securities Market legislation, hereby communicates the following:

 

OTHER RELEVANT INFORMATION

 

Within the current interest rate benchmark reform framework, and in connection with the two Bank issuances listed in Annex I of this notice (the "Issuances"), the Issuer has carried out a process to gather the consent from each and every investor of those Issuances for the purpose of: (i) replacing the reference interest rate "USD LIBOR" currently applied to those Issuances with the Secured Overnight Financing Rate - "SOFR", with the necessary adjustments detailed below, following the recommendations published by the Committee on Alternative Reference Rates ("ARRC"), and (ii) including the relevant supplementary robust clauses ("fallbacks") in the documentation of Issuances, given the possibility of a SOFR discontinuation.

 

In particular, the following modifications have been made to the Issuances:

 

- With regard to Series 3, the current interest rate is replaced with SOFR Compound 6 months (as defined in the Final Conditions attached) plus a margin of 0.92826% payable semi-annually. Once the consent of 100% of the holders has been received, the first interest payment date affected by the modification will be 17th October, 2023.

 

- With regard to Series 4, the current interest rate is replaced with SOFR Compound 6 months (as defined in the Final Conditions attached) plus a margin of 0.53826% payable semi-annually. Once the consent of 100% of the holders has been received, the first interest payment date affected by the modification will be 4th September, 2023.

 

New Final Conditions applicable to Series 3 and 4 are attached to this notice as Annex II.

Likewise, it is hereby stated that all the necessary communications have been made to the relevant bodies.

The foregoing is hereby disclosed as other relevant information for all relevant purposes.

 

Boadilla del Monte (Madrid), 3 May 2023.

 

 

 

ANNEX I

 

 

- "Issuance of Banco Santander, S.A. Internationalization Covered Bonds Series 3 - April 2027" ("Emisión de Cédulas de Internacionalización Banco Santander, S.A. Serie 3 - Abril 2027"), with ISIN code ES0413900657, for an amount of three thousand eight hundred million dollars (USD 3,800,000,000), whose Final Conditions were filed with the Spanish National Securities Market Commission on 21 April 2020 (the "Series 3").

 

- "Issuance of Banco Santander, S.A. Internationalization Covered Bonds Series 4 - March 2026" ("Emisión de Cédulas de Internacionalización Banco Santander, S.A. Serie 4 - Marzo 2026"), with ISIN code ES0413900707, for an amount of one billion dolars (USD 1,000,000,000), whose Final Conditions were filed with the Spanish National Securities Market Commission on 4 March 2021 (the "Series 4").

 

 

 

 

 

 

ANNEX II

 

New Final Conditions applicable to Series 3

New Final Conditions applicable to Series 4

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAJMMTMTJMBIJ
Date   Source Headline
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
25th Apr 20237:00 amRNS1Q2023 Results - Press release
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.